Showing results (2951-2960 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Antitumor properties of vindesine-monoclonal antibody conjugatesG F Rowland, C A Axton, R W Baldwin, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Influence in vitro on NK and K cell activities by cimetidine and indomethacin with and without simultaneous exposure to interferonP Flodgren, H O Sjögren
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Further studies on the differences in cytotoxicity of human peripheral blood monocytes and bronchoalveolar macrophages for cultured human lung cellsS Swinburne, M Moore, P Cole
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Monocyte chemotaxis in patients with nonseminomatous testicular carcinoma. Effect of chemotherapyH Nielsen, M Rørth, J Bennedsen
Cancer Immunology, Immunotherapy : CII|January 1, 1985
DR antigens expressed on tumor cells do not contribute to the blastogenetic response of autologous T cellsF Vánky, E Klein, J Willems
Cancer Immunology, Immunotherapy : CII|June 21, 2014
Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantationBrenda De Keersmaecker, Karel Fostier, Jurgen Corthals, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Induction of an endogenous tumor necrosis factor in mice by murine recombinant interferon-gamma combined with a lipid A subunit analog (GLA-60) of low toxicityI Saiki, H Maeda, T Sakurai, et al.
Cancer Immunology, Immunotherapy : CII|January 26, 2015
Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrenceMarcin Okroj, Emelie Holmquist, Elise Nilsson, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2012
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancerNadeem A Sheikh, Daniel Petrylak, Philip W Kantoff, et al.
Cancer Immunology, Immunotherapy : CII|August 8, 2012
The antitumor effect of the toll-like receptor 3 ligand polyinosinic-cytidylic acid as an adjuvantYu-Kun Huang, Zhi Zheng, Chun-Xia Cheng, et al.
Pageof 652